La vendita allo scoperto per Rani Therapeutics Hldgs dà agli investitori un'idea del grado in cui gli investitori stanno scommettendo sul declino delle azioni di Rani Therapeutics Hldgs. I dati relativi alle vendite allo scoperto vengono aggiornati ogni due settimane.

Rani Therapeutics Hldgs (NASDAQ:RANI) Azioni, Report sulle vendite allo scoperto

Rani Therapeutics Hldgs

Rani Therapeutics Holdings Inc is a clinical-stage biotherapeutics company advancing technologies to enable the development of orally administered biologics to provide patients, physicians, and healthcare systems with a convenient alternative to painful injections. The company has developed the RaniPill capsule, which is designed to deliver a wide variety of drug substances, including antibodies, proteins, peptides, and oligonucleotides. RaniPill is a proprietary and patented platform technology, intended to replace subcutaneous or IV injection of biologics with oral dosing. The company is also engaged in developing RaniPill HC, which is intended to enable the delivery of drug payloads up to 200 microlitre in liquid form with high bioavailability.

Rani Therapeutics Holdings, Inc. - Class A Common Stock

Rani Therapeutics Holdings Inc

Adobe (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ADBE#NASDAQ">ADBE</a>) has outperformed the market over the past 10 years by 10.33% on an annualized basis producing an average annual return of 21.51%. Currently, Adobe has a market capitalization of $221.46 billion. 
Buying $1000 In ADBE: If an investor had bought $1000 of ADBE stock 10 years ago, it would be worth $7,016.66 today based on a price of $503.09 for ADBE at the time of writing.
<h3>Adobe's Performance Over Last 10 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1730914362_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

News

Trading Ideas

ADBE

If You Invested $1000 In This Stock 10 Years Ago, You Would Have $7,000 Today

Digital Realty Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DLR#NYSE">DLR</a>) has outperformed the market over the past 20 years by 5.74% on an annualized basis producing an average annual return of 14.08%. Currently, Digital Realty Trust has a market capitalization of $57.56 billion. 
Buying $1000 In DLR: If an investor had bought $1000 of DLR stock 20 years ago, it would be worth $14,055.33 today based on a price of $173.72 for DLR at the time of writing.
<h3>Digital Realty Trust's Performance Over Last 20 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1730914357_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

If You Invested $1000 In This Stock 20 Years Ago, You Would Have $14,000 Today

Shares of SolarEdge Technologies Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SEDG#NASDAQ">SEDG</a>) dropped 20% to $15.06 during Wednesday&#8217;s session. Several solar stocks are trading lower following Donald Trump&#8217;s <a href="https://www.benzinga.com/news/large-cap/24/11/41774549/trumps-big-tech-policies-what-gop-victory-means-for-apple-google-microsoft">presidential election victory</a>.
The Republican Party's gains across the House and Senate signal a potential shift away from the green energy policies that have bolstered SolarEdge's business model. 
Trump's campaign commitments included reducing federal support for renewables and easing regulations on fossil fuel industries, which poses a threat to SolarEdge's growth trajectory and the broader renewable energy sector.
What To Know: Trump's proposed energy agenda includes plans to phase out green energy tax incentives, such as the Federal Investment Tax Credit (FITC), which currently provides a 30% tax credit for solar installations.
Concerns could mount among investors that if Trump repeals or scales back this incentive, it could impact demand for solar installations in the U.S., especially in states that lack their own substantial renewable energy subsidies.
SolarEdge, a leading provider of solar inverters and energy management solutions, relies heavily on the continued expansion of solar power adoption. 
With the possible withdrawal of federal tax benefits, SolarEdge could face serious headwinds, as potential customers may be deterred by higher upfront costs in the absence of tax relief, which could stall the company's momentum in a key market.
Read Also: <a href="https://www.benzinga.com/news/large-cap/24/11/41774549/trumps-big-tech-policies-what-gop-victory-means-for-apple-google-microsoft">Trump&#8217;s Big Tech Policies: What GOP Victory Means For Apple, Google, Microsoft</a>
Impact of Potential Tariffs and Trade Policies: Additionally, Trump's stance on tariffs poses a potential risk to SolarEdge's supply chain. Trump has floated the idea of a universal 10% tariff on all imports, and a <a href="https://www.benzinga.com/news/24/11/41737933/trump-tariff-proposed-may-cost-americans-78b-in-spending-study">possible 60% tariff</a> on Chinese goods could have direct repercussions.
SolarEdge sources some of its key components from international suppliers, particularly in Asia. If such tariffs were enacted, the costs of inverters and other equipment could rise sharply, squeezing the company's margins or forcing it to pass on these costs to consumers, further challenging its competitive positioning in the U.S. market.
What Else: Trump&#8217;s previous administration took a deregulatory approach toward environmental policy, rolling back numerous climate and emissions regulations. Given Trump's preference for traditional energy sectors, SolarEdge could see a policy landscape less supportive of renewable energy initiatives and one more favorable to fossil fuels. 
Without strong Federal backing, the solar industry may struggle to maintain its current growth, potentially impacting SolarEdge's revenue from its U.S. operations, which constitute a significant portion of its business.
Read Also: <a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/11/41778433/s-p-500-dow-hit-record-highs-after-trump-win-fear-index-drops-20">S&amp;P 500, Dow Hit Record Highs After Trump Win; Fear Index Drops 20%</a>
<h2 class="wp-block-heading">Should I Sell My SEDG Stock?</h2>
When deciding to hold on to or sell a stock, investors should consider their time horizon, unrealized gains and total return.
Shares of SolarEdge Technologies have decreased by 78.4% in the past year. An investor who bought shares of SolarEdge Technologies at the beginning of the year would take a loss of $76.39 per share if they sold it today. The stock has fallen 17.51% over the past month, meaning an investor who bought shares on Oct. 1 would see a capital loss of $6.33.
For access to advanced charting and analysis tools and stock data, check out <a href="https://pro.benzinga.com/">Benzinga PRO. Try it for free.</a>
SEDG has a 52-week high of $103.15 and a 52-week low of $14.82.

SEDG

Why SolarEdge Technologies (SEDG) Stock Is Down 20%

TD Cowen analyst Bill Kirk maintains TPG (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TPG#NASDAQ">TPG</a>) with a Hold and lowers the price target from $62 to $58.

Price Target

Analyst Ratings

TD Cowen Maintains Hold on TPG, Lowers Price Target to $58

Goldman Sachs analyst Bruno Montanari maintains Xometry (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/XMTR#NASDAQ">XMTR</a>) with a Buy and raises the price target from $24 to $28.

XMTR

Goldman Sachs Maintains Buy on Xometry, Raises Price Target to $28

Live On CNBC: Steve Weiss Buys CRH Public Limited Company

Sysco's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SYY#NYSE">SYY</a>) short percent of float has fallen 15.52% since its last report. The company recently reported that it has 13.89 million shares sold short, which is 2.83% of all regular shares that are available for trading. Based on its trading volume, it would take traders 4.6 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock/">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest">List of the most shorted stocks</a>
<h3>Sysco Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1730914223_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for Sysco has declined since its last report. This does not mean that the stock is going to rise in the near-term but traders should be aware that less shares are being shorted.
<h3>Comparing Sysco's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://pro.benzinga.com/">Benzinga Pro</a>, Sysco's peer group average for short interest as a percentage of float is 4.32%, which means the company has less short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze/">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

Short Sellers

Short Ideas

How Is The Market Feeling About Sysco?

Fabrinet's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FN#NYSE">FN</a>) short percent of float has risen 6.82% since its last report. The company recently reported that it has 1.47 million shares sold short, which is 5.64% of all regular shares that are available for trading. Based on its trading volume, it would take traders 4.32 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock/">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest">List of the most shorted stocks</a>
<h3>Fabrinet Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1730914218_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for Fabrinet has grown since its last report. This does not mean that the stock is going to fall in the near-term but traders should be aware that more shares are being shorted.
<h3>Comparing Fabrinet's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://pro.benzinga.com/">Benzinga Pro</a>, Fabrinet's peer group average for short interest as a percentage of float is 2.91%, which means the company has more short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze/">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

(FN) - Analyzing Fabrinet's Short Interest

AvalonBay Communities's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AVB#NYSE">AVB</a>) short percent of float has fallen 12.16% since its last report. The company recently reported that it has 2.97 million shares sold short, which is 2.89% of all regular shares that are available for trading. Based on its trading volume, it would take traders 4.95 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock/">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest">List of the most shorted stocks</a>
<h3>AvalonBay Communities Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1730914213_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for AvalonBay Communities has declined since its last report. This does not mean that the stock is going to rise in the near-term but traders should be aware that less shares are being shorted.
<h3>Comparing AvalonBay Communities's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://pro.benzinga.com/">Benzinga Pro</a>, AvalonBay Communities's peer group average for short interest as a percentage of float is 3.89%, which means the company has less short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze/">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

(AVB) - Analyzing AvalonBay Communities's Short Interest

ROIC

Trading Halt: Halt status updated at 12:30:00 PM ET: Quotation Resumption: News and Resumption Times

TD Cowen analyst Joseph Giordano maintains Sensata Technologies (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ST#NYSE">ST</a>) with a Buy and lowers the price target from $50 to $45.

TD Cowen Maintains Buy on Sensata Technologies, Lowers Price Target to $45

Goldman Sachs analyst Salveen Richter maintains uniQure (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QURE#NASDAQ">QURE</a>) with a Neutral and lowers the price target from $10 to $9.

QURE

Goldman Sachs Maintains Neutral on uniQure, Lowers Price Target to $9

WIIM

AMBA

INTC

LSCC

MRVL

NVDA

NXPI

QCOM

SLAB

Shares of companies in the broader semiconductor and chip sector are trading higher amid overall market strength following the US presidential election.

SMRT

SmartRent shares are trading lower after the company reported worse-than-expected Q3 financial results.

Montrose Environmental Group shares are trading lower after B of A Securities downgraded the stock from Buy to Neutral and cut its price target from $52 to $29.

Ero Copper shares are trading lower after the company reported worse-than-expected Q3 financial results. Also, the company's co-founder and chairman retired.

TD Cowen analyst Jason Seidl maintains GXO Logistics (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GXO#NYSE">GXO</a>) with a Buy and raises the price target from $82 to $83.

TD Cowen Maintains Buy on GXO Logistics, Raises Price Target to $83

Goldman Sachs analyst George Tong maintains UL Solutions (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ULS#NYSE">ULS</a>) with a Neutral and raises the price target from $45 to $51.

Goldman Sachs Maintains Neutral on UL Solutions, Raises Price Target to $51

TD Cowen analyst Joseph Giordano maintains Xylem (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XYL#NYSE">XYL</a>) with a Hold and lowers the price target from $138 to $125.

TD Cowen Maintains Hold on Xylem, Lowers Price Target to $125

Goldman Sachs analyst Michael Ng maintains Super Micro Computer (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SMCI#NASDAQ">SMCI</a>) with a Neutral and lowers the price target from $67.5 to $28.

SMCI

Goldman Sachs Maintains Neutral on Super Micro Computer, Lowers Price Target to $28

Maxim Group analyst Michael Okunewitch has maintained their bullish stance on RANI stock, giving a Buy rating today. Michael Okunewitch's rating is...

Innovative Oral Delivery Platform Drives Buy Rating for Rani Therapeutics Holdings

Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Merus (MRUS – Research Report), Staar Surgical (ST...

Analysts Conflicted on These Healthcare Names: Merus (MRUS), Staar Surgical (STAA) and Rani Therapeutics Holdings (RANI)

There's a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Hoth Therapeutics (HOTH – Research Report), Rewalk R...

Analysts Offer Insights on Healthcare Companies: Hoth Therapeutics (HOTH), Rewalk Robotics (LFWD) and Rani Therapeutics Holdings (RANI)

H.C. Wainwright analyst Mitchell Kapoor reiterated a Buy rating on Rani Therapeutics Holdings (RANI – Research Report) today and set a price target...

Buy Rating Maintained for Rani Therapeutics: A Financial and Risk Analysis Amidst Recent Equity Financing

Investors have plenty to feel positive about. Inflation is easing, with the latest data showing an annualized rate of 2.4%, just shy of the Fed's t...

Oppenheimer Predicts up to 740% Rally for These 2 'Strong Buy' Stocks

Tevogen Bio, Rani Therapeutics, and Expion360 are the 3 Penny Stocks to watch on October 15, 2024, based on&nbsp;TipRanks' Penny Stock Screener too...

3 Penny Stocks to Watch Now, 10/15/24

Rani Therapeutics to sell 3M shares at $3.00 in registered direct offering

Rani Therapeutics Holdings (RANI – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Mitchell ...

Buy Rating Affirmed for Rani Therapeutics: Promising Developments in Oral Obesity Treatment with RaniPill™

There's a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Avadel Pharmaceuticals (AVDL – Research Report) and ...

Analysts Are Bullish on These Healthcare Stocks: Avadel Pharmaceuticals (AVDL), Rani Therapeutics Holdings (RANI)

Maxim Group analyst Michael Okunewitch has maintained their bullish stance on RANI stock, giving a Buy rating on October 18. Michael Okunewitch has...

Comments

Rani Therapeutics Hldgs

Vendite allo scoperto

Rani Therapeutics Hldgs (NASDAQ:RANI) Azioni, Report sulle vendite allo scoperto

Le persone guardano anche

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO